MT-102（Micromet）

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameMT-102（Micromet）

Drug Alias NameMT-102（Micromet）

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-EpCAM

TargetsEpithelial cell adhesion molecule

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMicromet Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMicromet Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A